Luminus Diagnostics Attends American Association for Geriatric Physciatry


ATLANTA, GA., March 3, 2019 – Luminus Diagnostics, a full-service specialty lab based in Tifton, Georgia, was in attendance at the annual American Association of Geriatric Psychology (AAGP) held in Atlanta, GA (March 1-4, 2019) to introduce Amplis™ Medication Guidance Reporting, a decision support tool for clinicians based on advanced genetic technologies, to attendees at the conference hall. The newly-offered test can provide physicians and patients with insight into proper medication guidance.

The AAGP 2019 conference theme focuses on “Engage for Change: Preparing and Partnering for the Future of Geriatric Mental Health” which highlights the importance of advocacy and partnerships to help ensure older Americans have access to high quality care for mental health and substance use disorders. The meeting aims to help participants better understand the key policy issues that impact our ability to provide care to our patients, conduct research on late-life mental illness and its effective treatments, and train the workforce needed to provide high quality care now and in the future.

Luminus Diagnostics developed testing methods for Amplis™ Medication Guidance, opening the doors to potential future scientific findings, developments and research in the geriatric psychiatry field.

The company is excited to bring Amplis™ to the American Association for Geriatric Psychiatry (AAGP) annual meeting and unveil it to the psychiatric health community for geriatrics, physicians and geriatric patients. As attendees begin making their way into the exhibition hall, Luminus Diagnostic employees are preparing to illuminate the industry to an important and invaluable genetic test.

Recent Research suggests that depressed patients who received antidepressants medication for the first time, responded well only 15% – 30% of the time. These odds could improve significantly as the test becomes more widely utilized by licensed psychiatric professionals for their patients, as Amplis studies have shown it works up to 72% of the time on first medication chosen.

Luminus Diagnostics is a full-service, specialty laboratory and integrated technology platform designed to illuminate patient insight, streamline ordering and optimize practice performance. Providing advanced technology integration to streamline practice diagnostic ordering with timely, accurate testing and exceptional customer service.

Luminus attends AAGP Annual Meeting

Luminus attended the 2019 American Association for Geriatric Psychiatry Annual Meeting (March 1 – March 4)



0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.